Deflazacort is a glucocorticoid corticosteroid used to treat inflammatory autoimmune and allergic conditions It is known for having less impact on bone metabolism and glucose tolerance compared to other corticosteroids like prednisolone
Available Strengths
Tablet Strengths Typical Use
6 mg Mild to moderate inflammation
12 mg Moderate to severe conditions
18 mg 30 mg Highdose therapy eg DMD
Uses Indications
Duchenne Muscular Dystrophy DMD a major approved indication
Rheumatoid arthritis lupus polymyositis
Severe allergies skin conditions eczema psoriasis
Nephrotic syndrome
Asthma bronchitis COPD exacerbations
Inflammatory bowel disease Crohns ulcerative colitis
Posttransplant immunosuppression
Autoimmune hematological disorders eg ITP
Dosage Administration
Condition Typical Dose
General inflammation 618 mg once daily
DMD Duchenne 09 mgkgday
Autoimmune conditions Individualized based on response
Always take after food to reduce stomach upset
Morning dose preferred to mimic natural cortisol rhythm
Do not stop suddenly taper gradually as per physicians advice
Precautions
Use with caution in
Diabetes or prediabetes
Hypertension
Osteoporosis
Peptic ulcers
Infections latent or active TB fungal infections
May suppress immune response avoid live vaccines
Longterm use in children may affect growth
Possible Side Effects
Common Serious Longterm
Weight gain increased appetite Osteoporosis cataracts glaucoma
Mood changes insomnia Growth suppression in children
Indigestion bloating Adrenal suppression
Acne fluid retention Increased infection risk
Drug Interactions
Can interact with
Antidiabetic drugs effectiveness
NSAIDs GI bleeding risk
Antifungals anticonvulsants alter metabolism
Vaccines efficacy avoid live vaccines
Storage
Store below 25C
Keep in a dry place away from sunlight
Keep out of reach of children
No file chosen